You are here: Home » Companies » News
AWS to invest $4.4 bn in India by 2030 through new Hyderabad region service
Business Standard

Glenmark Pharma inks settlement pact with Pfizer for cancer treatment drug

The Mumbai-based drug maker and its US-based unit have inked a settlement pact with drug major Pfizer Inc for Axitinib Tablets (1 mg and 5 mg)

Topics
Glenmark Pharmaceuticals | Pfizer | cancer drugs

Press Trust of India  |  New Delhi 



Glenmark Pharmaceuticals
Glenmark said its current portfolio consists of 177 products authorised for distribution in the US marketplace and 47 abbreviated new drug applications (ANDA's) are pending for approval with the US Food and Drug Administration.

on Tuesday said it has entered into a settlement agreement with Inc regarding a cancer treatment drug.

The Mumbai-based drug maker and its US-based unit have inked a settlement pact with drug major Inc for Axitinib Tablets (1 mg and 5 mg).

Glenmark's product is the generic version of Pfizer's Inlyta tablets, used to treat kidney cancer.

According to IQVIATM sales data for the 12-month period ending September 2022, the Inlyta tablets (1 mg and 5 mg) achieved annual sales of around USD 644.5 million.

Glenmark said its current portfolio consists of 177 products authorised for distribution in the US marketplace and 47 abbreviated new drug applications (ANDA's) are pending for approval with the US Food and Drug Administration.

Shares of of the drug maker were trading 1.54 per cent up at Rs 417.9 apiece on BSE.

(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)


Subscribe to Business Standard Premium

Exclusive Stories, Curated Newsletters, 26 years of Archives, E-paper, and more!

Insightful news, sharp views, newsletters, e-paper, and more! Unlock incisive commentary only on Business Standard.

Download the Business Standard App for latest Business News and Market News .

First Published: Tue, November 22 2022. 14:15 IST

RECOMMENDED FOR YOU

.